Antimicrobial Agents and Chemotherapy · 2004 · 85 citations · 7 references
MedicinePharmacokineticsPharmacologyAntimicrobial PharmacologyAntimicrobial PharmacotherapyClinical PharmacologyAntibacterial TherapyAntimicrobial DosingAntimicrobial PharmacodynamicsAntimicrobial TherapyDe-escalation Of Antimicrobial TherapyPharmacokinetics Of AntimicrobialsDosage Regimen OptimizationEmpirical Antimicrobial TreatmentExtended Infusion DosingPharmacodynamic OptimizationPharmacodynamic TargetingPharmacokinetic-pharmacodynamic OptimizationPseudomonas Aeruginosa Infection TreatmentPseudomonas Aeruginosa Resistance
A Monte Carlo simulation demonstrated that 1 g of meropenem (MEM) every 8 h (q8h) (3-h infusion) has a higher target attainment rate against Pseudomonas aeruginosa than either 500 mg of MEM q8h (3-h infusion) or 0.5 g of imipenem-cilastatin (I-C) q6h (1-h infusion). For other pathogens, 500 mg of MEM q8h was equivalent or superior to I-C.
7
The pharmacokinetics of meropenem.
George L. Drusano, Michael G. Hutchison · PubMed · 1995 · 83 citations